Sign in →

Pendred (SLC26A4) Sequencing

Important Note

As of 12/31/24 this test will no longer be performed by the Seattle Children’s Molecular Genetics Laboratory. Seattle Children’s Hospital providers can consider alternate options at the Molecular Otolaryngology and Renal Research Laboratories at the University of Iowa.  External providers should contact the MORL or their preferred reference laboratory to coordinate test orders, specimen collection, and billing directly.  

Synonyms

DFNB4

Description

The Seattle Children's Hospital Molecular Laboratory no longer offers this test.

Sample Requirements

See reference lab instructions.

Performing Laboratory

Varies

Department

Lab Client Services: labclientservices@seattlechildrens.org

 

Lab Genetic Counselor: LabGC@seattlechildrens.org

Special Instructions

Links to: Pendred Syndrome/DFNB4 - GeneReview

Clinical Utility

Pathogenic variants in the SLC26A4 gene can cause Pendred syndrome (PDS) and DFNB4. Pendred syndrome is an autosomal recessive syndromic disorder characterized by bilateral sensorineural hearing impairment (typically congenital), vestibular dysfunction, temporal bone abnormalities such as enlargement of the vestibular aqueduct (EVA), and euthyroid goiter. DFNB4 is an autosomal recessive form of nonsyndromic deafness characterized by vestibular dysfunction and EVA without thyroid defects. SLC26A4 pathogenic variants may account for 7-13% of all congenital hearing impairment.  SLC26A4 pathogenic variants account for approximately half of PDS/DFNB4 cases and are the second most common cause of genetic hearing impairment.